Welcome to The CAPS Community!

Recent Stock Pitches

• Outperform
  Rewalk Robotics (RWLK)

  6 hours ago by HDTVBG (< 20) | Reply

  I've been in this for real since shortly after the IPO, averaging down over time. Just doubled down one last time near the historic low so my total cost basis is now around four bucks. This is going to 80, plenty of time left to get on board. Ins... More

• Underperform
  Copytele Inc Com (ITUS)

  13 hours ago by RES7 (98.92) | Reply

  otc reporter

• Outperform
  Centene Corp (CNC)

  14 hours ago by larvalbug (22.70) | Reply

  Low P/S, no excessive debt, positive levered FCF, mid-cap, good ROE, above 50- and 200-day moving averages. Good prospects.

• Underperform
  Cytrx Corp (CYTR)

  15 hours ago by SmartAce (99.93) | Reply

  Rick Astley will let you borrow any movie from his Pixar collection except for one.
  He's never gonna give you Up.

• Outperform
  Applied DNA Sciences Inc. (APDN)

  15 hours ago by OklaBoston (63.81) | Reply

  Big jump on highest volume in 6 months, with over 14% insider ownership.

• Outperform
  MOMO Inc. (MOMO)

  16 hours ago by Jordrok (96.99) | Reply

  Strong growth.

• Outperform
  TOP Tankers, Inc. (TOPS)

  17 hours ago by stocky5 (37.91) | Reply

  Pirating the high seas for dumb and dumber investors. Reverse split of 1 for 20 shares followed six weeks later by 1 for 15 shares, yet the company finds additional suckers to feed their equity draining scam. DryShips Jr.

• Outperform
  Wayfair (W)

  17 hours ago by Mkandolin (51.63) | Reply

  With the move to eCommerce becoming so massive, I believe this will be another big player in the eCommerce space.

• Outperform
  Alibaba (BABA)

  20 hours ago by Culpower (< 20) | Reply

  Excellent management in Jack Ma who can unlock huge potential in China

• Underperform
  Chesapeake Energy Corp (CHK)

  21 hours ago by Freeze703 (23.68) | Reply

  Bottom of the barrel - barring $4 NG, safe bet

• Outperform
  American Reprographics Company (ARC)

  22 hours ago by OklaBoston (63.81) | Reply

  Bottomy technicals and valuations, primarily.

• Outperform
  Hovnanian Enterprises Inc (HOV)

  June 25, 2017 by OklaBoston (63.81) | Reply

  Valuations and improving technicals.

• Underperform
  Under Armour, Inc. (UAA)

  June 25, 2017 by getrichdietrying (82.61) | Reply

  When your company's CEO gets involved in politics you reflect what you espoused. Now he is using "alternative facts" such as his company is the only best one in the world and whining that it's unfair that "Nike isn't playi... More

• Outperform
  Gerdau S.A. (ADR) (GGB)

  June 25, 2017 by OklaBoston (63.81) | Reply

  Great valuations and over 30% insider ownership.
  
  Testing support technically at the moment but the support should hold, IMO.

• Outperform
  The Goodyear Tire & Rubber Company (GT)

  June 25, 2017 by john603 (71.03) | Reply

  Cost cutting. Share buybacks.

• Outperform
  PayPal Holdings (PYPL)

  June 25, 2017 by newbuddha (73.03) | Reply

  Leader in digital wallet-based payments. Will continue to grow base of users profitably as digital payments are adopted globally.

• Outperform
  Monster Beverage Corp. (MNST)

  June 25, 2017 by cgall75 (< 20) | Reply

  Coke distribution should expand growth, brand recognition has staying power, new hydro drink looks like it will take market share from sports drink market (Gatorade etc..)

• Outperform
  Teekay Corp (TK)

  June 25, 2017 by zarrpac (< 20) | Reply

  Free cash flow machine, stock price down without change in earnings estimates sentiment.

• Outperform
  Taro Pharmaceutical Industries Ltd. (TARO)

  June 25, 2017 by zarrpac (< 20) | Reply

  Negative sentiment due to pricing pressures on pharmaceutical industry. The stock is not covered by wall street analysts. But the company has an excellent business and a narrow moat in its niche dermatological segment which makes up bulk of revenue. ... More

• Outperform
  Depomed Inc (DEPO)

  June 25, 2017 by zarrpac (< 20) | Reply

  Value of its products worth more than its current market value. Temporary overhang caused by pricing pressures on pharmaceuticals.